Israel’s Teva Lifts Outlook With War Not Curbing Drug Production
Teva Pharmaceutical Industries Ltd., one of Israel’s largest companies, increased its revenue guidance for the second straight quarter,
1970-01-01 08:00
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
1970-01-01 08:00
Berlusconi Office Backing $100 Million Pharma Startup Qualifyze
Qualifyze is closing in on a fundraising that could value the pharmaceutical compliance data firm at about $100
1970-01-01 08:00
Gilead Recovers as Quarterly Revenue Reassures Investors
Gilead Sciences Inc. shares erased a decline as a strong quarterly performance more than offset a lower profit
1970-01-01 08:00
Private Equity Backers of Plan B Morning-After Pill Weigh $4 Billion Sale of Company
The private equity owners of Foundation Consumer Healthcare are exploring a potential sale of the company behind popular
1970-01-01 08:00
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
1970-01-01 08:00
Teva Weighs Sale of $2 Billion Active Ingredients Unit
Teva Pharmaceutical Industries Ltd. is weighing options for its active ingredients business, including a possible sale, people with
1970-01-01 08:00
Teva Plans to Cut Back Generic Drug Production Even As Shortages Intensify
Teva Pharmaceutical Industries Ltd. plans to cut back manufacturing of generic drugs, citing low profitability, at a time
1970-01-01 08:00
White House Assembles Secret Team to Tackle Drug Shortages, Quality Woes
As US drug shortages hit a five-year high and concerns mount about the safety of medicines, the Biden
1970-01-01 08:00